Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their medicine as prescribed, according to a new study.
from Skin Care News -- ScienceDaily https://ift.tt/33IhDLO
No comments:
Post a Comment